Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

LEIDEN, The Netherlands--(BUSINESS WIRE)--Aug 10, 2026-

Bruker Takes Majority Stake in dutch MIMETAS as Organoid Technologies Move Into the Mainstream - European Biotechnology Magazine

The U.S. analytical technology group is acquiring a majority stake in Dutch organ-on-a-chip specialist MIMETAS, bringing human tissue models into its broader portfolio of multiomics, spatial biology and preclinical imaging. The deal is another sign that organoids and microphysiological systems are moving from specialized research tools toward integrated platforms for drug discovery. The post Bruker Takes Majority Stake in dutch MIMETAS as Organo…

Azunic AI Selects RASTRUM to Power Human-Relevant 3D In Vitro Toxicology Platform

LEHI, Utah--(BUSINESS WIRE)--Azunic AI today announced the selection of Inventia Life Science’s RASTRUM 3D cell culture platform to support the development of its animal-free toxicology platform and advance human-relevant preclinical safety assessment. Azunic AI will use RASTRUM to develop induced pluripotent stem cell (iPSC)-derived 3D models across toxicity-relevant organ systems. The platform will provide the scale, reproducibility, and assay…